 Autolus Therapeutics NASDAQ:AUTL and LogicBio Therapeutics NASDAQ:LOGC are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership. Institutional Insider Ownership 31.7 of Autolus Therapeutics shares are owned by institutional investors. Comparatively, ... 